{
    "case_number": "CAC-UDRP-100536",
    "time_of_filling": "2012-12-02 15:59:08",
    "domain_names": [
        "buycheaplexapro.com"
    ],
    "case_administrator": "Lada Válková (Case admin)",
    "complainant": [
        "H. Lundbeck A\/S"
    ],
    "complainant_representative": "Wallberg IP Advice",
    "respondent": [
        "Fundacion Private Whois Dom. Admin."
    ],
    "respondent_representative": null,
    "factual_background": "The Complainant H. Lundbeck A\/S is an international pharmaceutical company engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at disorders such as depression and anxiety, psychotic disorders, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases.\r\nLundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today Lundbeck employs approximately 6,000 people worldwide.\r\n\r\nLundbeck is one of the world's leading pharmaceutical companies working with brain disorders. In 2011, the company's revenue was DKK 16.0 billion (approximately EUR 2.2 billion or USD 3.0 billion). For more information, reference is made to the official website www.lundbeck.com.\r\n\r\nLundbeck markets a number of different pharmaceuticals for the treatment of brain disorders. The most recently launched compounds include (using the Complainant's registered trademarks): Cipralex\/Lexapro (depression), Ebixa (Alzheimer’s disease), Azilect (Parkinson’s disease), Xenazine (chorea associated with Huntington's disease), Sabril (epilepsy), Sycrest (bipolar disorder) and Onfi (Lennox-Gastaut syndrome).\r\n\r\nThe trademark Lexapro has been registered by the Complainant in more than 100 countries around the world.\r\n\r\nThe Respondent has registered and is using the contested domain name without the Complainant's consent for a website that contains pay-per-clock links and advertisements for businesses other than the Complainant, some of them in the pharmaceutical sector. \r\n",
    "other_legal_proceedings": "None",
    "no_response_filed": "No administratively compliant response has been filed.\r\n\r\n",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the Domain Name is identical or confusingly similar to a trademark or service mark in which the complainant has rights (within the meaning of paragraph 4(a)(i)of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the Domain Name (within the meaning of paragraph 4(a)(ii)of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the Domain Name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii)of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Jonathan Turner"
    ],
    "date_of_panel_decision": "2013-01-12 00:00:00",
    "informal_english_translation": "The Complainant owns a large number of registered trademarks worldwide comprising the word 'LEXAPRO', inter alia the international trademark registration no. 778106 “LEXAPRO” (word) with registration date 16 March 2002.",
    "decision_domains": {
        "BUYCHEAPLEXAPRO.COM": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}